Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-7cwtggNot yet recruiting
Randomised, open-label trial of propofol, remifentanil and sevoflurane in cholelithiasis (2 arms), sponsored by Faculdade de Medicina de Jundiaí. Primary endpoint: Quality of postoperative functional recovery. Planned start Oct 2017; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-7cwtgg.